过去一年中添加的文章，按日期排序
[HTML][HTML] Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals
F Benetti, A Araújo, I de Maman Júnior… - … of Endocrinology and …, 2024 - SciELO Brasil
57 天前 - SciELO - Brasil - Impact of sustained virologic response on glucose parameters
among patients with chronic hepatitis C treated with direct-acting antivirals Impact of sustained …
among patients with chronic hepatitis C treated with direct-acting antivirals Impact of sustained …
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
T Ogata, T Sakai, S Shibata, H Kanno, H Nakane… - Surgical Case …, 2024 - Springer
71 天前 - … not accept interferon therapy for chronic hepatitis C. He was … direct-acting antiviral
(DAA) therapy. However, DAA … DAA therapy for patients with decompensated cirrhosis was …
(DAA) therapy. However, DAA … DAA therapy for patients with decompensated cirrhosis was …
Improvement in Thrombocytopenia after Direct Acting Anti-Viral (DAA) Therapy in Patients with Hepatitis C Virus-Related Chronic Liver Disease in Pakistani …
N Ali, N Ahmed, RTY Khan, MM ul Haq… - Journal of Health and …, 2024 - jhrlmc.com
78 天前 - … acting antivirals (DAAs) have revolutionized HCV treatment due to their high efficacy
and favorable safety profiles but the impact on … criteria encompassed decompensated liver …
and favorable safety profiles but the impact on … criteria encompassed decompensated liver …
Cost-Effectiveness of Strategies for Treatment Timing for Perinatally Acquired Hepatitis C Virus
MR Curtis, RL Epstein, P Pei, BP Linas… - JAMA …, 2024 - jamanetwork.com
113 天前 - … Direct-acting antiviral (DAA) therapy was recently … The clinical and economic impacts
of early DAA therapy for … In this analysis, individuals with decompensated cirrhosis or HCC …
of early DAA therapy for … In this analysis, individuals with decompensated cirrhosis or HCC …
Impact of new direct‐acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection
118 天前 - Background Patients with chronic hepatitis C (CHC) can be cured with the new
highly effective interferon‐free combination treatments (DAA) that were approved in 2014. …
highly effective interferon‐free combination treatments (DAA) that were approved in 2014. …
Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China
…, X Chen, J Yang, H Bai, Y Long, X Zhang, C Lin - BMC …, 2024 - Springer
139 天前 - … genotype direct-acting antiviral agent (DAA) for hepatitis C virus … of cirrhosis and
decompensated cirrhosis in ECS group (… effects of ECS and DNV in Chinese chronic hepatitis C …
decompensated cirrhosis in ECS group (… effects of ECS and DNV in Chinese chronic hepatitis C …
Using Multiple Contact Networks in an Agent-Based Model to Track Hepatitis C Elimination in an Ongoing Pandemic Era
210 天前 - … of effective direct-acting antiviral therapy, whether … goals on schedule with the
ongoing impact of the COVID-19 … the reported incidence of CHC, decompensated cirrhosis (DC), …
ongoing impact of the COVID-19 … the reported incidence of CHC, decompensated cirrhosis (DC), …